CAVALLI, FRANCESCO
CAVALLI, FRANCESCO
Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease
2020-01-01 Cazzola, M; Cavalli, F; Usmani, Os; Rogliani, P
An overview of the safety and efficacy of monoclonal antibodies for the chronic obstructive pulmonary disease
2021-01-01 Cazzola, M; Ora, J; Cavalli, F; Rogliani, P; Matera, Mg
Biomarkers for possible early detection and progression of idiopathic pulmonary fibrosis
2021-01-01 Cavalli, F; Puxeddu, E; Teodori, E; Sforza, M; de Marco, P; Rogliani, P
CD71- Alveolar Macrophages in Idiopathic Pulmonary Fibrosis: A Look beyond the Borders of the Disease
2019-01-01 Puxeddu, E; Fraboni, D; Cillis, G; Cavalli, F; Buccisano, F; Rogliani, P
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score
2022-08-01 Rogliani, P; Ora, J; Cavalli, F; Cazzola, M; Calzetta, L
Delivering monoclonal antibodies via inhalation: a systematic review of clinical trials in asthma and COPD
2023-01-01 Laitano, R; Calzetta, L; Cavalli, F; Cazzola, M; Rogliani, P
Does bronchoscopy help the diagnosis in COVID-19 infection?
2020-01-01 Ora, J; Puxeddu, E; Cavalli, F; Giorgino, Fm; Girolami, A; Chiocchi, M; Sergiacomi, G; Federici, M; Rogliani, P
Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological models
2022-06-01 Calzetta, L; Pistocchini, E; Ritondo, Bl; Cavalli, F; Camardelli, F; Rogliani, P
New avenues for phosphodiesterase inhibitors in asthma
2021-01-01 Matera, Mg; Ora, J; Cavalli, F; Rogliani, P; Cazzola, M
Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile
2022-01-01 Rogliani, P; Cavalli, F; Chetta, A; Cazzola, M; Calzetta, L
Road Toward a New Model of Care for Idiopathic Pulmonary Fibrosis in the Lazio Region
2022-01-01 Di Bidino, R; Rogliani, P; Sebastiani, A; Ricci, A; Varone, F; Sgalla, G; Iovene, B; Bruni, T; Flore, Mc; D'Ascanio, M; Cavalli, F; Savi, D; Di Michele, L; Cicchetti, A; Richeldi, L
Sex differences in adult asthma and COPD therapy: a systematic review
2022-08-29 Rogliani, P; Cavalli, F; Ritondo, Bl; Cazzola, M; Calzetta, L
Synergy across the drugs approved for the treatment of asthma
2022-01-01 Rogliani, P; Ritondo, Bl; Cavalli, F; Giorgino, Fm; Girolami, A; Pane, G; Pezzuto, G; Zerillo, B; Puxeddu, E; Ora, J
Treatable Mechanisms in Asthma
2021-01-01 Cazzola, M; Ora, J; Cavalli, F; Rogliani, P; Matera, Mg
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2020 | Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease | Cazzola, M; Cavalli, F; Usmani, Os; Rogliani, P | Articolo su rivista | |
| 1-gen-2021 | An overview of the safety and efficacy of monoclonal antibodies for the chronic obstructive pulmonary disease | Cazzola, M; Ora, J; Cavalli, F; Rogliani, P; Matera, Mg | Articolo su rivista | |
| 1-gen-2021 | Biomarkers for possible early detection and progression of idiopathic pulmonary fibrosis | Cavalli, F; Puxeddu, E; Teodori, E; Sforza, M; de Marco, P; Rogliani, P | Articolo su rivista | |
| 1-gen-2019 | CD71- Alveolar Macrophages in Idiopathic Pulmonary Fibrosis: A Look beyond the Borders of the Disease | Puxeddu, E; Fraboni, D; Cillis, G; Cavalli, F; Buccisano, F; Rogliani, P | Articolo su rivista | |
| 1-ago-2022 | Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score | Rogliani, P; Ora, J; Cavalli, F; Cazzola, M; Calzetta, L | Articolo su rivista | |
| 1-gen-2023 | Delivering monoclonal antibodies via inhalation: a systematic review of clinical trials in asthma and COPD | Laitano, R; Calzetta, L; Cavalli, F; Cazzola, M; Rogliani, P | Articolo su rivista | |
| 1-gen-2020 | Does bronchoscopy help the diagnosis in COVID-19 infection? | Ora, J; Puxeddu, E; Cavalli, F; Giorgino, Fm; Girolami, A; Chiocchi, M; Sergiacomi, G; Federici, M; Rogliani, P | Articolo su rivista | |
| 1-giu-2022 | Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological models | Calzetta, L; Pistocchini, E; Ritondo, Bl; Cavalli, F; Camardelli, F; Rogliani, P | Articolo su rivista | |
| 1-gen-2021 | New avenues for phosphodiesterase inhibitors in asthma | Matera, Mg; Ora, J; Cavalli, F; Rogliani, P; Cazzola, M | Articolo su rivista | |
| 1-gen-2022 | Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile | Rogliani, P; Cavalli, F; Chetta, A; Cazzola, M; Calzetta, L | Articolo su rivista | |
| 1-gen-2022 | Road Toward a New Model of Care for Idiopathic Pulmonary Fibrosis in the Lazio Region | Di Bidino, R; Rogliani, P; Sebastiani, A; Ricci, A; Varone, F; Sgalla, G; Iovene, B; Bruni, T; Flore, Mc; D'Ascanio, M; Cavalli, F; Savi, D; Di Michele, L; Cicchetti, A; Richeldi, L | Articolo su rivista | |
| 29-ago-2022 | Sex differences in adult asthma and COPD therapy: a systematic review | Rogliani, P; Cavalli, F; Ritondo, Bl; Cazzola, M; Calzetta, L | Articolo su rivista | |
| 1-gen-2022 | Synergy across the drugs approved for the treatment of asthma | Rogliani, P; Ritondo, Bl; Cavalli, F; Giorgino, Fm; Girolami, A; Pane, G; Pezzuto, G; Zerillo, B; Puxeddu, E; Ora, J | Articolo su rivista | |
| 1-gen-2021 | Treatable Mechanisms in Asthma | Cazzola, M; Ora, J; Cavalli, F; Rogliani, P; Matera, Mg | Articolo su rivista |